1
/
of
2
Tresivac (Live Attenuated Measles, Mumps and Rubella Virus)
Tresivac (Live Attenuated Measles, Mumps and Rubella Virus)
Regular price
₱1,424.00 PHP
Regular price
Sale price
₱1,424.00 PHP
Taxes included.
Quantity
Couldn't load pickup availability
Tresivac is a live attenuated MMR vaccine offering protection against measles, mumps, and rubella in a single dose. Measles causes high fever, characteristic rash, and serious complications including pneumonia and encephalitis. Mumps leads to salivary gland swelling and can result in meningitis or orchitis. Rubella poses significant risks to pregnant women and fetal development.
Tresivac provides immunization for children starting at 12-15 months, with a second dose recommended at 4-6 years. The vaccine is suitable for infants, children, teens, and adults requiring MMR protection. As a live attenuated formulation from a trusted manufacturer, Tresivac delivers proven efficacy in preventing these three serious viral diseases while maintaining an established safety profile.
Vaccination protects individual health and strengthens community immunity against measles, mumps, and rubella transmission.
Tresivac provides immunization for children starting at 12-15 months, with a second dose recommended at 4-6 years. The vaccine is suitable for infants, children, teens, and adults requiring MMR protection. As a live attenuated formulation from a trusted manufacturer, Tresivac delivers proven efficacy in preventing these three serious viral diseases while maintaining an established safety profile.
Vaccination protects individual health and strengthens community immunity against measles, mumps, and rubella transmission.
Share
